BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Arcturus Therapeutics Issues Statement

  The company issued a response to the filing issued by the ousted CEO.

  February 7, 2018

   · 

  2 min read
• Business

  Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO

  Mr. Miesch joins Osiris as an independent Board Member and will stand for election at the Company’s 2018 Stockholders Meeting.

  February 7, 2018

   · 

  2 min read
• Cobra Biologics and Symbiosis Awarded £1.9m ($2.5m USD) Innovate UK Grant

  The grant will position the partner companies as globally recognised centres of excellence in the field and firmly establish commercial viral vector manufacturing capabilities within the UK.

  February 7, 2018

   · 

  2 min read
• Business

  Natus Medical Announces Fourth Quarter and Full Year 2017 Financial Results

  For the fourth quarter ended December 31, 2017, the Company reported revenue of $131.4 million, an increase of 22.0% compared to $107.7 million reported for the fourth quarter 2016.

  February 7, 2018

   · 

  16 min read
• Drug Development

  Saniona Completes Recruitment in Phase I Study With New Tesomet tablet

  The trial is comprised of a total of 60 volunteers.

  February 7, 2018

   · 

  2 min read
• Business

  Cate Lockhart Appointed Program Director of Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)

  The Biologics and Biosimilars Collective Intelligence Consortium is pleased to announce that Cate Lockhart, PharmD, PhD, has been appointed BBCIC Program Director.

  February 7, 2018

   · 

  2 min read
• Edmond De Rothschild Investment Partners Closes EUR 345 Million BioDiscovery 5 fund

  BioDiscovery 5 includes investments from current and new investors, with investors representing more than 60% of BioDiscovery 4 choosing to reinvest in BioDiscovery 5.

  February 7, 2018

   · 

  2 min read
• 

  FDA

  Mesa Biotech Wins FDA OK and CLIA Waiver for its Accula Point of Care Flu A/Flu B Test

  The company’s Flu A/Flu B test cassette will be its first available test in the U.S. market.

  February 7, 2018

   · 

  3 min read
• SCHOTT AG, ARaymondlife and Vanrx Pharmasystems Announce Product Compatibility for Primary Packaging of Sterile Injectables

  This Product Set is fully commercially available and ready-to-use, with closure integrity performance results available from the suppliers.

  February 7, 2018

   · 

  4 min read
• Ipsen Announces Eight Oral Presentations from Its Neurosciences Portfolio at the 10th World Congress for Neurorehabilitation (WCNR)

  The meeting takes place in Mumbai, India, February 7-10, 2018.

  February 7, 2018

   · 

  16 min read